LENZ Therapeutics (LENZ) Operating Leases: 2022-2023
Historic Operating Leases for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $49.7 million.
- Therapeutics' Operating Leases rose 1888.00% to $49.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $49.7 million, marking a year-over-year increase of 1888.00%. This contributed to the annual value of $1.7 million for FY2022, which is N/A change from last year.
- Therapeutics' Operating Leases amounted to $49.7 million in Q3 2023, which was down 1.83% from $50.6 million recorded in Q2 2023.
- Therapeutics' 5-year Operating Leases high stood at $50.6 million for Q2 2023, and its period low was $1.4 million during Q1 2023.
- In the last 2 years, Therapeutics' Operating Leases had a median value of $3.3 million in 2022 and averaged $16.3 million.
- Over the last 5 years, Therapeutics' Operating Leases had its largest YoY gain of 1,888.00% in 2023, and its largest YoY loss of 68.76% in 2023.
- Over the past 2 years, Therapeutics' Operating Leases (Quarterly) stood at $1.7 million in 2022, then skyrocketed by 1,888.00% to $49.7 million in 2023.
- Its Operating Leases stands at $49.7 million for Q3 2023, versus $50.6 million for Q2 2023 and $1.4 million for Q1 2023.